|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/31/18 Sarepta Therapeutics, Inc. 10-Q 9/30/18 82:9.8M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Srpt Q3 2018 10-Q Filing HTML 988K
2: EX-10.1 Material Contract HTML 81K
3: EX-10.2 Material Contract HTML 71K
4: EX-10.3 Material Contract HTML 63K
5: EX-10.4 Material Contract HTML 79K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 29K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 29K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 26K
16: R1 Document and Entity Information HTML 48K
17: R2 Condensed Consolidated Balance Sheets HTML 106K
18: R3 Condensed Consolidated Balance Sheets HTML 48K
(Parenthetical)
19: R4 Condensed Consolidated Statements of Operations HTML 90K
and Comprehensive Loss
20: R5 Condensed Consolidated Statements of Cash Flows HTML 157K
21: R6 Organization and Nature of Business HTML 31K
22: R7 Summary of Significant Accounting Policies and HTML 58K
Recent Accounting Pronouncements
23: R8 Collaboration, License and Manufacturing HTML 42K
Agreements
24: R9 Fair Value Measurements HTML 144K
25: R10 Cash, Cash Equivalents and Marketable Securities HTML 202K
26: R11 Accounts Receivable and Reserves for Product Sales HTML 101K
27: R12 Inventory HTML 46K
28: R13 Other Current Assets and Other Non-Current Assets HTML 97K
29: R14 Accrued Expenses HTML 75K
30: R15 Indebtedness HTML 59K
31: R16 Restructuring HTML 50K
32: R17 Stock-Based Compensation HTML 152K
33: R18 Other Income and Loss HTML 73K
34: R19 Income Taxes HTML 27K
35: R20 Net Loss Per Share HTML 76K
36: R21 Commitments and Contingencies HTML 78K
37: R22 Subsequent Events HTML 31K
38: R23 Summary of Significant Accounting Policies and HTML 70K
Recent Accounting Pronouncements (Policies)
39: R24 Fair Value Measurements (Tables) HTML 139K
40: R25 Cash, Cash Equivalents and Marketable Securities HTML 202K
(Tables)
41: R26 Accounts Receivable and Reserves for Product Sales HTML 102K
(Tables)
42: R27 Inventory (Tables) HTML 46K
43: R28 Other Current Assets and Other Non-Current Assets HTML 99K
(Tables)
44: R29 Accrued Expenses (Tables) HTML 74K
45: R30 Indebtedness (Tables) HTML 56K
46: R31 Restructuring (Tables) HTML 49K
47: R32 Stock-Based Compensation (Tables) HTML 157K
48: R33 Other Income and Loss (Tables) HTML 73K
49: R34 Net Loss Per Share (Tables) HTML 76K
50: R35 Commitments and Contingencies (Tables) HTML 59K
51: R36 Organization and Nature of Business - Additional HTML 37K
Information (Detail)
52: R37 Summary of Significant Accounting Policies and HTML 49K
Recent Accounting Pronouncements - Additional
Information (Detail)
53: R38 Collaboration, License and Manufacturing HTML 117K
Agreements - Additional Information (Detail)
54: R39 Assets Measured and Carried at Fair Value (Detail) HTML 54K
55: R40 Summary of Company Financial Assets with HTML 32K
Maturities of Less Than 90 Days Included in Cash
Equivalents (Detail)
56: R41 Cash, Cash Equivalents and Marketable Securities - HTML 25K
Additional Information (Detail)
57: R42 Summary of Company Cash, Cash Equivalents and HTML 59K
Short-term Investments (Detail)
58: R43 Summary of Components of Accounts Receivable HTML 31K
(Detail)
59: R44 Summary of Change in Reserves for Discounts and HTML 42K
Allowances (Detail)
60: R45 Summary of Total Reserves Included in Consolidated HTML 29K
Balance Sheets (Detail)
61: R46 Inventory - Summary of Components of Inventory HTML 36K
(Detail)
62: R47 Summary of Other Current Assets (Detail) HTML 43K
63: R48 Summary of Other Non-current Assets (Detail) HTML 42K
64: R49 Summary of Accrued Expenses (Detail) HTML 56K
65: R50 Indebtedness - Additional Information (Detail) HTML 114K
66: R51 Indebtedness - Summary of Debt Facilities (Detail) HTML 44K
67: R52 Restructuring - Additional Information (Detail) HTML 41K
68: R53 Summary of Restructuring Reserve (Detail) HTML 36K
69: R54 Summary of Stock Awards Granted (Detail) HTML 41K
70: R55 Stock Based Compensation - Additional Information HTML 27K
(Detail)
71: R56 Summary of Stock-Based Compensation Expense by HTML 33K
Function Included within Condensed Consolidated
Statements of Operations and Comprehensive Loss
(Detail)
72: R57 Summary of Stock-Based Compensation Expense by HTML 35K
Grant Type Included within Condensed Consolidated
Statements of Operations and Comprehensive Loss
(Detail)
73: R58 Summary of Other Income and Loss (Detail) HTML 40K
74: R59 Basic and Diluted Net Loss Per Share (Detail) HTML 42K
75: R60 Basic and Diluted Net Loss Per Share HTML 26K
(Parenthetical) (Detail)
76: R61 Commitments and Contingencies - Additional HTML 38K
Information (Detail)
77: R62 Summary of Aggregate Non-Cancelable Future Minimum HTML 43K
Payments under Company's Leases (Detail)
78: R63 Summary of Aggregate Non-Cancelable Contractual HTML 36K
Obligations Arising from Manufacturing Obligations
(Detail)
79: R64 Subsequent Events - Additional Information HTML 57K
(Detail)
81: XML IDEA XML File -- Filing Summary XML 143K
80: EXCEL IDEA Workbook of Financial Reports XLSX 78K
10: EX-101.INS XBRL Instance -- srpt-20180930 XML 2.47M
12: EX-101.CAL XBRL Calculations -- srpt-20180930_cal XML 202K
13: EX-101.DEF XBRL Definitions -- srpt-20180930_def XML 357K
14: EX-101.LAB XBRL Labels -- srpt-20180930_lab XML 1.06M
15: EX-101.PRE XBRL Presentations -- srpt-20180930_pre XML 752K
11: EX-101.SCH XBRL Schema -- srpt-20180930 XSD 185K
82: ZIP XBRL Zipped Folder -- 0001564590-18-025831-xbrl Zip 155K
EXHIBIT 10.3
SAREPTA THERAPEUTICS, INC.
2018 EQUITY INCENTIVE PLAN
RESTRICTED STOCK UNIT AWARD AGREEMENT
NOTICE OF RESTRICTED STOCK UNIT GRANT
Participant: [Name of Participant]
Address:
The above-named Participant (the “Participant”) has been granted the number of restricted stock units (the “RSUs”) set forth below giving the Participant the conditional right to receive, without payment therefor, one share of Common Stock of Sarepta Therapeutics, Inc. (the “Company”) with respect to each RSU forming part of the award, pursuant and subject to the terms and conditions of the 2018 Equity Incentive Plan (the “Plan”) and this Restricted Stock Unit Award Agreement, including this Notice of Restricted Stock Unit Grant (the “Notice of Grant”) and the Terms and Conditions of Restricted Stock Unit Grant attached hereto as Exhibit A, (this “Award Agreement”), as follows:
|
Date of Grant |
|
|
|
|
|
|
|
Vesting Commencement Date |
|
|
|
|
|
|
|
Number of RSUs |
|
|
Vesting Schedule
Subject to the terms and conditions of the Plan and this Award Agreement, the RSUs will vest, in accordance with the following vesting schedule, with the number of RSUs that vest on the first vesting date being rounded up to the nearest whole share, the number of RSUs that vest on any subsequent vesting date being rounded down to the nearest whole share and 100% of the RSUs becoming vested on the final vesting date:
[INSERT VESTING SCHEDULE]
Notwithstanding the foregoing, in the event the Participant’s relationship with the Company (and/or a Subsidiary) as a Service Provider terminates as a result of the Service Provider’s death, 100% of the RSUs will vest as of the date of such death.
Agreements and Acknowledgements
The Participant has reviewed the Plan and this Award Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Award Agreement and fully understands all provisions of the Plan and this Award Agreement. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and this Award Agreement. The Participant further agrees to notify the Company upon any change in the residence address indicated above.
Further, the Participant acknowledges and agrees that (i) this Award Agreement may be executed in two or more counterparts, each of which will be an original and all of which together will constitute one and the same instrument, (ii) this Award Agreement may be executed and exchanged using facsimile, portable document format (PDF) or electronic signature, which, in each case, will constitute an original signature for all purposes hereunder, and (iii) such signature by the Company will be binding against the Company and will create a legally binding agreement when this Award Agreement is countersigned by the Participant.
|
PARTICIPANT
|
|
SAREPTA THERAPEUTICS, INC. |
|
Signature
|
|
By |
|
Print Name |
|
Title |
TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT GRANT
1.Grant of Restricted Stock Units. The Company hereby grants to the Participant the number of RSUs set forth in the Notice of Grant that forms a part of this Award Agreement giving the Participant the conditional right to receive, without payment therefor, one share of Common Stock with respect to each RSU forming part of the award pursuant and subject to the terms and conditions of the Plan and this Award Agreement.
2.Vesting Schedule. Unless earlier terminated, forfeited, relinquished or expired and subject to the Participant’s continuous relationship with the Company (and/or a Subsidiary) as a Service Provider from the Date of Grant through each applicable vesting date, the RSUs will vest in accordance with the vesting provisions set forth in the Notice of Grant.
3.Company’s Obligation to Pay. Subject to Section 4 below, the Company shall, as soon as practicable upon the vesting of any portion of the RSUs awarded hereunder (but in no event later than 30 days following the date on which such RSUs vest), effect delivery of the Shares with respect to such vested RSUs to the Participant (or, in the event of the Participant’s death, the Beneficiary (as defined below)).
4.Forfeiture upon Termination of Relationship with Company as a Service Provider; Death of Participant.
(a)Except as otherwise provided in any employment or change of control or similar individual agreement between the Company and the Participant, upon the termination of the Participant’s relationship with the Company (and/or a Subsidiary) as a Service Provider for any reason other than the death of the Participant, any then outstanding and unvested RSUs will be automatically and immediately forfeited.
(b)In the event the Participant’s relationship with the Company (and/or a Subsidiary) as a Service Provider terminates as a result of the Participant’s death, 100% of the RSUs will vest as of the date of such death.
5.Death of Participant. Any delivery to be made to the Participant under this Award Agreement will, if the Participant is then deceased, be made to the beneficiary named in the written designation (in a form acceptable to the Administrator) most recently filed with the Administrator by the Participant and not subsequently revoked, or if there is no such designated beneficiary, by the executor or administrator of the Participant’s estate (in each case, the “Beneficiary”). Any delivery under this Award Agreement to a Beneficiary will be subject to the Company receiving appropriate proof of the right of the Beneficiary to receive such distribution or delivery, as the case may be, as determined by the Administrator.
6.Tax Obligations.
(a)Withholding Taxes. The vesting of the RSUs awarded hereunder, and the payment of any vested dividend equivalents with respect to such RSUs, will give rise to “wages” subject to withholding. The Participant expressly acknowledges and agrees that the Participant’s rights hereunder, including the right to be issued Shares upon vesting of the RSUs, are subject to the Participant promptly paying all taxes required to be withheld to the Company in cash, by check, with consideration received by the Company under any formal broker-assisted program implemented by the Company in connection with the Plan or by the surrender of Shares with a Fair Market Value on the date of surrender equal to the amount of all taxes required to be withheld, provided that accepting such Shares, in the sole discretion of the Administrator, will not result in any adverse accounting consequences to the Company (or by such other means as may be acceptable to the Administrator). No Shares will be transferred pursuant to the vesting of the RSUs unless and until the Participant has remitted to the Company an amount in cash or by check sufficient to satisfy any federal, state, local, foreign or provincial withholding tax requirements, or has made other arrangements satisfactory to the Administrator with respect to such taxes. The Participant authorizes the Company and its Subsidiaries to withhold such amount from any amounts otherwise owed to the Participant, but nothing in this sentence may be construed as relieving the Participant of any liability for satisfying his or her obligation under the preceding provisions of this Section.
(b)Participant Acknowledgment. Regardless of any action taken by the Company or its Subsidiaries, the Participant acknowledges and agrees that the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, capital/gains tax, payment on account or other tax-related items related to the RSU and the Participant’s participation in the Plan (“Tax-Related Items”) is and remains the Participant’s sole responsibility and may exceed the amount, if any, withheld by the Company or its Subsidiaries. The Participant further acknowledges that the Company and/or its Subsidiaries (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSU, including the grant, vesting or payment of the RSU, the subsequent sale of any Shares underlying the RSU that have been paid and the receipt of any dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSU to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant becomes subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable or tax withholding event, the Participant acknowledges and agrees that the Company and/or its Subsidiaries may be required to withhold or account for Tax-Related Items in more than one jurisdiction
7.Dividend Equivalents. Cash dividend equivalents on Shares underlying RSUs shall be credited to a dividend equivalent book entry account on behalf of the Participant with respect to each RSU granted to a Participant, provided that such cash dividend equivalents shall not be deemed to be reinvested in Shares and will be held uninvested and without interest and paid in cash if and when the shares underlying the RSU vest and are paid to the Participant. Stock dividend equivalents on Shares shall be credited to a dividend equivalent book entry account on behalf of the Participant with respect to each RSU granted to a Participant, provided that the Participant shall not be entitled to such dividend equivalents unless and until the shares underlying the RSU vest and are paid to the Participant.
8.Rights as Stockholder. Until the RSUs vest and the Shares underlying such vested RSUs are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to the RSUs. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 15(a) of the Plan.
9.No Guarantee of Continued Service. Neither the grant of the RSUs, nor the issuance of Shares upon the vesting of any portion of the RSUs, will give the Participant any right to be retained in the employ or service of the Company or any of its subsidiaries, affect the right of the Company or any of its subsidiaries to discharge the Participant at any time, or affect any right of the Participant to terminate his or her employment or service at any time.
10.Grant is Not Transferable. This award of RSUs may not be transferred except as expressly permitted under Section 5 of this Award Agreement or Section 14 of the Plan.
11.Additional Conditions to Issuance of Shares. The Company will not be obligated to deliver any Shares under this Award Agreement until: (i) the Company is satisfied that all legal matters in connection with the issuance and delivery of such Shares have been addressed and resolved; (ii) if the outstanding Common Stock is at the time of delivery listed on any stock exchange or national market system, the shares to be delivered have been listed or authorized to be listed on such exchange or system upon official notice of issuance; and (iii) all conditions in this Award Agreement have been satisfied or waived. The Company may require, as a condition to the delivery of Shares under this Award Agreement or the vesting of such Shares, such representations or agreements as counsel for the Company may consider appropriate to avoid violation of any federal securities law (including, without limitation, the Securities Act of 1933, as amended), any applicable state or non-U.S. securities law or rule of any applicable stock exchange or national market system.
12. Provisions of the Plan. This Award Agreement is subject in its entirety to all terms and provisions of the Plan, which is incorporated herein by reference. In the event of a conflict between one or more provisions of this Award Agreement and one or more provisions of the Plan, the provisions of the Plan will govern. Capitalized terms used and not defined in this Award Agreement will have the meaning set forth in the Plan. A copy of the Plan as in effect on the Date of Grant has been furnished to the Participant. By accepting, or being deemed to have accepted, all or any part of the RSUs, the Participant agrees to be bound by the terms and conditions of the Plan and this Award Agreement.
13.Recoupment Policy; Stock Ownership Guidelines. This award of RSUs and any Shares issued pursuant to this Award Agreement will be subject to the Company’s Recoupment Policy and its Stock Ownership Guidelines, where applicable.
14.Electronic Delivery. The Company may decide to deliver any documents related to the RSUs awarded hereunder or future awards of restricted stock units that may be awarded under the Plan by electronic means or request the Participant’s consent to participate in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through any on-line or electronic system established and maintained by the Company or another third party designated by the Company.
15.Address for Notices. Any notice to be given to the Company under the terms of this Award Agreement will be addressed to the Company at Sarepta Therapeutics, Inc., 215 First Street, Suite 7, Cambridge, MA 02142, or at such other address as the Company may hereafter designate in writing.
16.Captions. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Award Agreement.
17.Agreement Severable. In the event that any provision in this Award Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Award Agreement.
18.Modifications to the Agreement. This Award Agreement constitutes the entire understanding of the parties on the subjects covered. The Participant expressly warrants that he or she is not accepting this Award Agreement in reliance on any promises, representations, or inducements other than those contained herein. The Administrator may at any time or times amend this Award Agreement for any purpose which may at the time be permitted by law; provided, however, that except as otherwise expressly provided herein or in the Plan the Administrator may not, without the Participant’s consent, alter the terms of this Award Agreement so as to affect materially and adversely the Participant’s rights under this Award Agreement. This Award Agreement and the award of RSUs hereunder is intended to be exempt from Section 409A of the Code. Notwithstanding anything to the contrary in the Plan or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems necessary or advisable, in its sole discretion and without the consent of the Participant, to comply with Section 409A of the Code, or to otherwise avoid imposition of any additional tax or income recognition under Section 409A of the Code in connection with this award of RSUs.
19.Limitation on Liability. Notwithstanding anything to the contrary in the Plan or this Award Agreement, neither the Company, nor any of its Subsidiaries, nor the Administrator, nor any person acting on behalf of the Company, any of its Subsidiaries, or the Administrator, will be liable to the Participant or to any Beneficiary by reason of any acceleration of income, or any additional tax (including any interest and penalties), asserted by reason of the failure of this award of RSUs to satisfy the requirements of Section 409A of the Code or by reason of Section 4999 of the Code, or otherwise asserted with respect to this award of RSUs.
20.Governing Law. This Award Agreement is governed by the laws of the State of Delaware, without giving effect to the conflict of law principles thereof. For purposes of litigating any dispute that arises under this award of RSUs or this Award Agreement, the parties hereby submit to and consent to the jurisdiction of the State of Delaware, and agree that such litigation will be conducted in the state courts of Delaware, or the federal courts for the United States for the District of Delaware, and no other courts, where this award of RSUs is made and/or to be performed.
21.Nature of Grant. In accepting the RSU, the Participant acknowledges and agrees that:
(a)the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;
(b)the grant of the RSU is voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past;
(c)all decisions with respect to future RSU grants, if any, will be at the sole discretion of the Company;
(d)the Participant’s participation in the Plan is voluntary;
(e)the RSU and the underlying Shares are extraordinary items that (i) do not constitute compensation of any kind for services of any kind rendered to the Company and/or any Subsidiary, and (ii) are outside the scope of the Participant’s employment or service contract, if any;
(f)the RSU and the underlying Shares and the income and value of the same, are not intended to replace any pension rights or compensation;
(g)the RSU and the underlying Shares and the income and value of the same, are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company and/or any Subsidiary;
(h)the future value of the underlying Shares is unknown and cannot be predicted with certainty, and the Shares acquired upon payment of the RSUs may increase or decrease in value;
(i)no claim or entitlement to compensation or damages shall arise from forfeiture of the RSU or diminution in value of the Shares acquired through vesting, forfeiture of the RSU resulting from the termination of the Participant’s employment by the Company and/or any Subsidiary or continuous service (for any reason whatsoever and, whether or not later found to be invalid or in breach of applicable labor laws or the terms of the Participant’s employment or service agreement, if any);
(j)for purposes of this RSU, regardless of the reason of the Participant’s termination (and whether or not later found to be invalid or in breach of applicable labor laws or the terms of the Participant’s employment or service agreement, if any), the Participant’s employment or service relationship will be considered terminated effective as of the date the Participant is no longer actively employed or providing services and will not be extended by any notice period mandated under local law (e.g., active employment would not include any contractual notice period or any period of “garden leave” or similar period pursuant to local law). The Administrator shall have the exclusive discretion to determine when the Participant is no longer actively employed for purposes of this RSU (including whether the Participant may still be considered to be providing services while on a leave of absence); and
(k)the Company and any Subsidiaries shall not be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the RSU or of any amounts due to the Participant pursuant to the exercise of the RSU or the subsequent sale of any Shares acquired upon payment of the RSUs.
22.Data Privacy.
The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant’s Data (as defined below) by and among, as necessary and applicable, the Company and any Subsidiaries for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Plan.
The Participant understands that the Company and/or Subsidiaries may hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, date of birth, social security or insurance number or other identification number, salary, nationality, and job title, any Common Stock or directorships held in the Company, and details of the RSU or any other RSU or other entitlement to Shares, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the purpose of implementing, administering and managing the Plan. The Participant understands that Data will be transferred to E*TRADE Securities LLC (including any of its affiliates and successors) or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan, that these recipients may be located in the Participant’s country or elsewhere, including outside the European Economic Area, and that the recipients’ country may have different data privacy laws and protections than the Participant’s country. The Participant authorizes the Company, E*TRADE Securities LLC (including any of its affiliates and successors) and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing the Participant’s participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Shares acquired upon vesting and payment of the RSU.
The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant’s local human resources representative. The Participant understands that Data shall be held as long as is reasonably necessary to implement, administer and manage the Participant’s participation in the Plan, and that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant’s local human resources representative. Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant’s consent, the Participant’s employment status or service and career with the Company and/or any Subsidiary will not be adversely affected; the only adverse consequence of refusing or withdrawing the Participant’s consent is that the Company would not be able to grant the Participant RSUs or other equity awards or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing such consent may affect the Participant’s ability to participate in the Plan. In addition, the Participant understands that the Company and its Subsidiaries have separately implemented procedures for the handling of Data which the Company believes permits the Company to use the Data in the manner set forth above notwithstanding the Participant’s withdrawal of such consent. For more information on the consequences of refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Participant’s local human resources representative.
23.Insider Trading Restrictions/Market Abuse Laws. The Participant acknowledges that, depending on the Participant’s country of residence, the Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect the Participant’s ability to acquire or sell Shares or rights to Shares under the Plan during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws in the Participant’s country). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant acknowledges that it is the Participant’s responsibility to comply with any applicable restrictions, and the Participant is advised to speak to the Participant’s personal advisor on this matter.
24.Foreign Asset/Account Reporting Requirements and Exchange Controls. The Participant’s country may have certain foreign asset and/or foreign account reporting requirements and exchange controls which may affect the Participant’s ability to acquire or hold Shares under the Plan or cash received from participating in the Plan (including from any dividends paid on Shares, sale proceeds resulting from the sale of Shares acquired under the Plan) in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets or transactions to the tax or other authorities in the Participant’s country. The Participant may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to the Participant’s country through a designated bank or broker within a certain time after receipt. The Participant acknowledges that it is the Participant’s responsibility to be compliant with such regulations, and the Participant should consult the Participant’s personal legal advisor for any details.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/31/18 | 10-Q/A, 4 | ||
| For Period end: | 9/30/18 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/28/24 Sarepta Therapeutics, Inc. 10-K 12/31/23 119:18M Donnelley … Solutions/FA 2/28/23 Sarepta Therapeutics, Inc. 10-K 12/31/22 119:23M Donnelley … Solutions/FA 3/01/22 Sarepta Therapeutics, Inc. 10-K 12/31/21 121:20M Donnelley … Solutions/FA 3/01/21 Sarepta Therapeutics, Inc. 10-K 12/31/20 124:22M ActiveDisclosure/FA |